US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even though the US Food and Drug Administration (FDA) previously gave the green light to the project – in a decision that could have implications for all new and updated vaccines in the US.
It’s the latest move by the Trump administration against vaccines. Officials in January decided to stop fully recommending one-third of routine childhood vaccines, including flu vaccines.
